Wegovy maker warns price cuts 'painful' for firm as shares plunge
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
